A cost analysis of participation via personal attendance versus telemedicine at a head and neck oncology multidisciplinary team meeting

Multidisciplinary team (MDT) meetings are used for establishing diagnosis, for tumour, node, metastasis (TNM) classification and for treatment in head and neck tumour patients in the western region of Sweden. Because of the distances, telemedicine was introduced to link the regional hospital to two of the three district general hospitals (DGHs). We evaluated the costs of presenting patients face to face (FTF) versus via telemedicine. Cost analyses were based on questionnaires completed by patients presented at the MDT meeting. A total of 39 patients were included in the FTF group and 45 patients in the telemedicine group. The cost analysis showed that FTF presentation cost SEK 2267 versus SEK 2036 by telemedicine (difference not significant). The small difference was explained by the fact that the responsible physician accompanied only six of 39 patients when presented FTF, but when presented via telemedicine the DGH physician always participated. A sensitivity analysis revealed that if the responsible physician always accompanied his/her patient for presentation FTF, the cost would be SEK 5366 per patient. This study shows that costs may be saved by carrying out MDT meetings by means of telemedicine instead of FTF.

[1]  M. Birchall,et al.  Performance and standards for the process of head and neck cancer care: South and West audit of head and neck cancer 1996–1997 (SWAHN I) , 2000, British Journal of Cancer.

[2]  G. Hordijk,et al.  Elderly patients with head and neck cancer: physical, social and psychological aspects after 1 year , 2004, Acta oto-laryngologica.

[3]  L. Machet.  [Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis]. , 2002, Annales de dermatologie et de venereologie.

[4]  H Lamminen,et al.  A cost study of teleconsultation for primary-care ophthalmology and dermatology , 2001, Journal of telemedicine and telecare.

[5]  T. Westin,et al.  Satisfaction with telemedicine presentation at a multidisciplinary tumour meeting among patients with head and neck cancer , 2003, Journal of telemedicine and telecare.

[6]  T. Westin,et al.  Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer , 2007, Acta oto-laryngologica.

[7]  F. Berrino,et al.  Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. , 1998, European journal of cancer.

[8]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[9]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[10]  C. R. Leemans,et al.  The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. , 2001, European journal of cancer.

[11]  E. Hammerlid,et al.  Effects of psychosocial intervention on quality of life in patients with head and neck cancer , 2003, Head & neck.

[12]  T. Bergmo,et al.  A cost-minimization analysis of a realtime teledermatology service in northern Norway , 2000, Journal of telemedicine and telecare.

[13]  D. Winchester.  The society of surgical oncology and the commission on cancer: Progress through synergism , 1998, Annals of Surgical Oncology.